Literature DB >> 29040635

Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.

Amanda Holyk1, Valerie Belden1, Jonathan J Lee2, William Musick1, Ryan Keul1, Gavin W Britz2, Jiejian Lin3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29040635     DOI: 10.1093/jac/dkx358

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Inhibition Activity of Avibactam against Nocardia farcinica β-Lactamase FARIFM10152.

Authors:  David Lebeaux; Clément Ourghanlian; Delphine Dorchène; Daria Soroka; Zainab Edoo; Fabrice Compain; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Successful Treatment of Ventriculitis Caused by MDR/XDR Gram-Negative Bacillus Using Ceftazidime/Avibactam: Case Series and Literature Review.

Authors:  Xiaofeng Yang; Liang Wen; Qian Zhou; Hao Wang; Tianxiang Zhan
Journal:  Infect Drug Resist       Date:  2021-05-05       Impact factor: 4.003

3.  In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.

Authors:  Wenxia Zhang; Yan Guo; Jiayin Li; Yiyuan Zhang; Yang Yang; Dong Dong; Demei Zhu; Ping He; Fupin Hu
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-21       Impact factor: 4.887

4.  Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases.

Authors:  Yasmin Coelho Patrial; Luma Petri Tortorelli; Ana Claudia Souza Rodrigues; Ivson Cassiano de Oliveira Santos; Cláudia Elizabeth Volpe-Chaves; Gislaine Souza Capato; Gustavo Augusto Ribeiro Barbosa; Ana Paula D'Alincourt Carvalho-Assef; Marilene Rodrigues Chang
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-12-20       Impact factor: 1.846

5.  Successful Treatment of Serious Meningitis Caused by Extremely Carbapenem-Resistant Enterobacter cloacae (MIC≥16mg/L) with i.v. Meropenem and i.v. Amikacin Plus Intraventricular Amikacin.

Authors:  Zheng He; Chengcheng Wang; Bin Liu; Maoyan Feng; Zhigang Wang
Journal:  Infect Drug Resist       Date:  2019-12-02       Impact factor: 4.003

6.  Intraventricular Plus Systemic Antibiotic Therapy for Treating Polymyxin-Resistant Klebsiella pneumoniae Ventriculitis: A Case Report.

Authors:  Hao Wang; Qian Zhou; Kaiyuan Huang; Xiaofeng Yang; Liang Wen
Journal:  Open Forum Infect Dis       Date:  2022-02-15       Impact factor: 3.835

7.  Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam.

Authors:  Mohamad Yasmin; Jennifer Hanrahan; Steven Marshall; Thomas P Lodise; Liang Chen; Federico Perez; Barry Kreiswirth; Robert A Bonomo
Journal:  Open Forum Infect Dis       Date:  2020-08-18       Impact factor: 3.835

8.  Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis.

Authors:  Erin K McCreary; Karin E Byers; Carolyn Fernandes; Ellen G Kline; David P Nicolau; Ryan K Shields
Journal:  Open Forum Infect Dis       Date:  2020-11-12       Impact factor: 4.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.